A

Active Biotech AB publ
STO:ACTI

Watchlist Manager
Active Biotech AB publ
STO:ACTI
Watchlist
Price: 0.291 SEK 76.58% Market Closed
Market Cap: 406m SEK
Have any thoughts about
Active Biotech AB publ?
Write Note

Intrinsic Value

ACTI's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one ACTI stock under the Base Case scenario is 0.064 SEK. Compared to the current market price of 0.291 SEK, Active Biotech AB publ is Overvalued by 78%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ACTI Intrinsic Value
0.064 SEK
Overvaluation 78%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation Backtest
Active Biotech AB publ

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ACTI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ACTI?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Active Biotech AB publ

Provide an overview of the primary business activities
of Active Biotech AB publ.

What unique competitive advantages
does Active Biotech AB publ hold over its rivals?

What risks and challenges
does Active Biotech AB publ face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Active Biotech AB publ.

Provide P/S
for Active Biotech AB publ.

Provide P/E
for Active Biotech AB publ.

Provide P/OCF
for Active Biotech AB publ.

Provide P/FCFE
for Active Biotech AB publ.

Provide P/B
for Active Biotech AB publ.

Provide EV/S
for Active Biotech AB publ.

Provide EV/GP
for Active Biotech AB publ.

Provide EV/EBITDA
for Active Biotech AB publ.

Provide EV/EBIT
for Active Biotech AB publ.

Provide EV/OCF
for Active Biotech AB publ.

Provide EV/FCFF
for Active Biotech AB publ.

Provide EV/IC
for Active Biotech AB publ.

Show me price targets
for Active Biotech AB publ made by professional analysts.

What are the Revenue projections
for Active Biotech AB publ?

How accurate were the past Revenue estimates
for Active Biotech AB publ?

What are the Net Income projections
for Active Biotech AB publ?

How accurate were the past Net Income estimates
for Active Biotech AB publ?

What are the EPS projections
for Active Biotech AB publ?

How accurate were the past EPS estimates
for Active Biotech AB publ?

What are the EBIT projections
for Active Biotech AB publ?

How accurate were the past EBIT estimates
for Active Biotech AB publ?

Compare the revenue forecasts
for Active Biotech AB publ with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Active Biotech AB publ and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Active Biotech AB publ against its competitors.

Analyze the profit margins
(gross, operating, and net) of Active Biotech AB publ compared to its peers.

Compare the P/E ratios
of Active Biotech AB publ against its peers.

Discuss the investment returns and shareholder value creation
comparing Active Biotech AB publ with its peers.

Analyze the financial leverage
of Active Biotech AB publ compared to its main competitors.

Show all profitability ratios
for Active Biotech AB publ.

Provide ROE
for Active Biotech AB publ.

Provide ROA
for Active Biotech AB publ.

Provide ROIC
for Active Biotech AB publ.

Provide ROCE
for Active Biotech AB publ.

Provide Gross Margin
for Active Biotech AB publ.

Provide Operating Margin
for Active Biotech AB publ.

Provide Net Margin
for Active Biotech AB publ.

Provide FCF Margin
for Active Biotech AB publ.

Show all solvency ratios
for Active Biotech AB publ.

Provide D/E Ratio
for Active Biotech AB publ.

Provide D/A Ratio
for Active Biotech AB publ.

Provide Interest Coverage Ratio
for Active Biotech AB publ.

Provide Altman Z-Score Ratio
for Active Biotech AB publ.

Provide Quick Ratio
for Active Biotech AB publ.

Provide Current Ratio
for Active Biotech AB publ.

Provide Cash Ratio
for Active Biotech AB publ.

What is the historical Revenue growth
over the last 5 years for Active Biotech AB publ?

What is the historical Net Income growth
over the last 5 years for Active Biotech AB publ?

What is the current Free Cash Flow
of Active Biotech AB publ?

Discuss the annual earnings per share (EPS)
trend over the past five years for Active Biotech AB publ.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Active Biotech AB publ

Current Assets 10.7m
Cash & Short-Term Investments 6.2m
Receivables 4.4m
Other Current Assets 100k
Non-Current Assets 4.2m
PP&E 3.5m
Intangibles 200k
Other Non-Current Assets 500k
Current Liabilities 11.5m
Other Current Liabilities 11.5m
Non-Current Liabilities 2m
Long-Term Debt 1.9m
Other Non-Current Liabilities 100k
Efficiency

Earnings Waterfall
Active Biotech AB publ

Revenue
0 SEK
Operating Expenses
-42.3m SEK
Operating Income
-42.3m SEK
Other Expenses
684k SEK
Net Income
-41.6m SEK

Free Cash Flow Analysis
Active Biotech AB publ

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ACTI Profitability Score
Profitability Due Diligence

Active Biotech AB publ's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

19/100
Profitability
Score

Active Biotech AB publ's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

ACTI Solvency Score
Solvency Due Diligence

Active Biotech AB publ's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Long-Term Solvency
Short-Term Solvency
Average D/E
45/100
Solvency
Score

Active Biotech AB publ's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACTI Price Targets Summary
Active Biotech AB publ

Wall Street analysts forecast ACTI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACTI is 0.622 SEK with a low forecast of 0.593 SEK and a high forecast of 0.664 SEK.

Lowest
Price Target
0.593 SEK
104% Upside
Average
Price Target
0.622 SEK
114% Upside
Highest
Price Target
0.664 SEK
128% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ACTI?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ACTI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Active Biotech AB publ

Country

Sweden

Industry

Biotechnology

Market Cap

406m SEK

Dividend Yield

0%

Description

Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.

Contact

SKANE
Lund
Scheelevagen 22
+4646192000.0
www.activebiotech.com

IPO

1986-12-01

Employees

-

Officers

President & CEO
Ms. Helen Tuvesson Ph.D.
Chief Financial Officer
Mr. Hans Kolam
Chief Medical Officer
Dr. Erik Vahtola

See Also

Discover More
What is the Intrinsic Value of one ACTI stock?

The intrinsic value of one ACTI stock under the Base Case scenario is 0.064 SEK.

Is ACTI stock undervalued or overvalued?

Compared to the current market price of 0.291 SEK, Active Biotech AB publ is Overvalued by 78%.

Back to Top